Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Summary

The primary purpose of this study is to assess the long-term safety and tolerability of Cannabidiol Oral Solution (CBD) in pediatric participants with treatment-resistant childhood absence seizures.

Timeline

Start

2018-02-20

Primary completion

2019-06-24

Completion

2019-06-28

Outcome

Outcome not reported

Stopped: “Insys Therapeutics filed Chapter 11 and terminated all studies.”

Drugs

Indications